Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit
The results of this study showed that after a slight adaptation, the Act-IP scale can be used to map clinical pharmacy activity in an HCT unit. More than 60% of the DRPs/PIs were likely to have had a positive impact on the patient's clinical outcome. All the PIs were rated with a positive organizational impact and PIs likely to lead to cost savings were balanced by those likely to increase costs.
Authors
- Paul Chauvet
- Valérie Coiteux (ORCID: https://orcid.org/0000-0002-0776-4615)
- David Beauvais (ORCID: https://orcid.org/0000-0003-1866-828X)
- Micha Srour (ORCID: https://orcid.org/0000-0002-8519-4187)
- Sixtine Gilliot (ORCID: https://orcid.org/0000-0001-7944-7443)
- Ibrahim Yakoub‐Agha (ORCID: https://orcid.org/0000-0003-4524-8782)
- Bertrand Décaudin (ORCID: https://orcid.org/0000-0001-8267-5594)
- Pascal Odou
- Michèle Vasseur (ORCID: https://orcid.org/0000-0001-7580-3471)
- Nicolas Simon (ORCID: https://orcid.org/0000-0001-5257-440X)
- Léonardo Magro
- Florence Quinet
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Lille Inflammation Research International Center (FR)
- Institute for Translational Research in Inflammation (FR)
- Groupe de Recherche sur les formes Injectables et les Technologies Associées
Publication Details
- Journal
- Journal of Oncology Pharmacy Practice
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1177/10781552241297391
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.34